rs17000462

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_004484.4(GPC3):​c.1413+9012T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0475 in 111,864 control chromosomes in the GnomAD database, including 321 homozygotes. There are 1,412 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.047 ( 321 hom., 1412 hem., cov: 23)

Consequence

GPC3
NM_004484.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.301

Publications

0 publications found
Variant links:
Genes affected
GPC3 (HGNC:4451): (glypican 3) Cell surface heparan sulfate proteoglycans are composed of a membrane-associated protein core substituted with a variable number of heparan sulfate chains. Members of the glypican-related integral membrane proteoglycan family (GRIPS) contain a core protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol linkage. These proteins may play a role in the control of cell division and growth regulation. The protein encoded by this gene can bind to and inhibit the dipeptidyl peptidase activity of CD26, and it can induce apoptosis in certain cell types. Deletion mutations in this gene are associated with Simpson-Golabi-Behmel syndrome, also known as Simpson dysmorphia syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
GPC3 Gene-Disease associations (from GenCC):
  • Simpson-Golabi-Behmel syndrome
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Simpson-Golabi-Behmel syndrome type 1
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.158 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004484.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GPC3
NM_004484.4
MANE Select
c.1413+9012T>C
intron
N/ANP_004475.1
GPC3
NM_001164617.2
c.1482+9012T>C
intron
N/ANP_001158089.1
GPC3
NM_001164618.2
c.1365+9012T>C
intron
N/ANP_001158090.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GPC3
ENST00000370818.8
TSL:1 MANE Select
c.1413+9012T>C
intron
N/AENSP00000359854.3
GPC3
ENST00000394299.7
TSL:1
c.1482+9012T>C
intron
N/AENSP00000377836.2
GPC3
ENST00000631057.2
TSL:1
c.1251+9012T>C
intron
N/AENSP00000486325.1

Frequencies

GnomAD3 genomes
AF:
0.0473
AC:
5288
AN:
111810
Hom.:
318
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.161
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0215
Gnomad ASJ
AF:
0.00717
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000748
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00844
Gnomad NFE
AF:
0.000807
Gnomad OTH
AF:
0.0384
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0475
AC:
5313
AN:
111864
Hom.:
321
Cov.:
23
AF XY:
0.0415
AC XY:
1412
AN XY:
34022
show subpopulations
African (AFR)
AF:
0.162
AC:
4964
AN:
30655
American (AMR)
AF:
0.0214
AC:
226
AN:
10548
Ashkenazi Jewish (ASJ)
AF:
0.00717
AC:
19
AN:
2649
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3551
South Asian (SAS)
AF:
0.000750
AC:
2
AN:
2665
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6107
Middle Eastern (MID)
AF:
0.00463
AC:
1
AN:
216
European-Non Finnish (NFE)
AF:
0.000807
AC:
43
AN:
53258
Other (OTH)
AF:
0.0379
AC:
58
AN:
1529
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
173
346
520
693
866
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0406
Hom.:
180
Bravo
AF:
0.0539

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.54
DANN
Benign
0.78
PhyloP100
-0.30
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17000462; hg19: chrX-132786746; API